There is great news for parents suffering the harrowing ordeal of their child needing a bone marrow transplant. The announcement came from Osiris Therapeutics Inc. (NASDAQ: OSIR) on Friday that Health Canada has approved its groundbreaking stem cell therapy Prochymal? (remestemcel-L). The drug can be used to treat children with acute graft-vs-host disease. (GvHD). The decision is a historic one, as it's both the first stem cell drug going into formal use, as well as the first treatment for GvHD...
Realtime Related Tweets
homeland homeland packers giants game golden globe winners 2012 ricky gervais golden globes epidermolysis bullosa miss wisconsin
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.